Curing hepatitis C reduces the risk of cardiovascular events in people with compensated cirrhosis, a large French study presented this week at the International Liver Congress in Amsterdam shows.
Presenting the findings, Patrice Cacoub of Hôpital Pitié-Salpêtrière, Paris, stressed the importance of thinking of hepatitis C as a systemic disease that affects the heart, the kidneys, blood vessels, the brain and glucose metabolism through mechanisms that are still to be fully understood. Hepatitis C is also associated with an increased risk of non-hepatic cancers, especially non-Hodgkin lymphoma.
Hepatitis C infection increases the risk of cardiovascular disease – events such as heart attack, stroke, peripheral artery disease and heart failure – especially in people with older people and those with diabetes or high blood pressure. Hepatitis C may promote heart disease by causing metabolic problems, but may also do so by causing inflammation.